Glaukos will exclusively market and sell the Radius XR wearable patient engagement and diagnostic system within the United States.
The novel Radius XR platform combines medical-grade diagnostics, business management tools, and patient education resources to enable more efficient detection of eye disease and better management and treatment of sight-threatening conditions. The RadiusExam and proprietary algorithms provide diagnostic testing results equivalent to current gold standards demonstrated through a clinical trial that shows statistical noninferiority of estimated sensitivities compared to SITA-Standard.
The RadiusExam and proprietary algorithms provide diagnostic testing results equivalent to current gold standards
This comprehensive hardware and software system provides the tools for medical professionals to diagnose patients accurately, enhance patient engagement, and reduce staff workload. It enables patients to perform self-guided vision tests with minimal supervision, aiding in eye care practices’ flow, efficiency, and patient experience.
“Today marks a notable milestone for Radius and more importantly, for patients suffering from chronic eye diseases. Glaukos is highly trusted and respected by vision care providers, and this collaboration will provide us with the necessary resources to expedite product development, optimise benefits for eye care providers, and enhance the overall quality of care and access for patients,” said Ammad Khan, Radius Chief Executive Officer (CEO).
“Through this partnership, Radius will benefit from Glaukos’ market-building expertise, leveraging its well-established sales team with extensive clinical knowledge and technical insight to commercialise and drive greater patient access for the Radius XR technology.”
“We are delighted to partner with Radius to strengthen commercialisation efforts and expand patient access for Radius’ innovative portable vision diagnostic system,” said Thomas Burns, Glaukos Chairman and CEO. “We believe the Radius XR platform is a novel technology that can help drive more efficient and improved diagnosis for patients suffering from chronic eye diseases, while also creating efficiency and growth opportunities for eye care practices. This collaboration aligns with our mission to meaningfully advance the standard of care and improve outcomes for patients suffering from chronic eye diseases.”
Radius will continue to lead development and commercialisation efforts for Radius XR.
